Spravato Den europeiske union - svensk - EMA (European Medicines Agency)

spravato

janssen-cilag international nv - esketamine hydroklorid - depression - andra antidepressiva - spravato, i kombination med ssri eller snri-preparat, är indicerat för vuxna med terapiresistent egentlig depression, som inte har svarat på minst två olika behandlingar med antidepressiva läkemedel i den aktuella måttlig till svår depressiv episod.

Methylphenidate Orion 54 mg Depottablett Sverige - svensk - Läkemedelsverket (Medical Products Agency)

methylphenidate orion 54 mg depottablett

orion corporation - metylfenidathydroklorid - depottablett - 54 mg - laktosmonohydrat hjälpämne; metylfenidathydroklorid 44,28 mg aktiv substans; metylfenidathydroklorid 9,72 mg aktiv substans

Methylphenidate Orion 18 mg Depottablett Sverige - svensk - Läkemedelsverket (Medical Products Agency)

methylphenidate orion 18 mg depottablett

orion corporation - metylfenidathydroklorid - depottablett - 18 mg - laktosmonohydrat hjälpämne; metylfenidathydroklorid 3,24 mg aktiv substans; metylfenidathydroklorid 14,76 mg aktiv substans

Zabdeno Den europeiske union - svensk - EMA (European Medicines Agency)

zabdeno

janssen-cilag international n.v.    - recombinant adenovirus type 26 (ad26) encoding the glycoprotein (gp) of the ebola virus zaire (zebov) mayinga strain - hemorragisk feber, ebola - vacciner - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.

Mvabea Den europeiske union - svensk - EMA (European Medicines Agency)

mvabea

janssen-cilag international n.v.    - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - hemorragisk feber, ebola - vacciner - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.

Jcovden (previously COVID-19 Vaccine Janssen) Den europeiske union - svensk - EMA (European Medicines Agency)

jcovden (previously covid-19 vaccine janssen)

janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - vacciner - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older. användning av detta vaccin bör ske i enlighet med officiella rekommendationer.

Rybrevant Den europeiske union - svensk - EMA (European Medicines Agency)

rybrevant

janssen-cilag international n.v.    - amivantamab - carcinom, non-small cell lung - antineoplastiska medel - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.

Methylphenidate Generis 27 mg Depottablett Sverige - svensk - Läkemedelsverket (Medical Products Agency)

methylphenidate generis 27 mg depottablett

generis farmacêutica, sa - metylfenidathydroklorid - depottablett - 27 mg - metylfenidathydroklorid 22,14 mg aktiv substans; metylfenidathydroklorid 4,86 mg aktiv substans; laktosmonohydrat hjälpämne

Methylphenidate Generis 18 mg Depottablett Sverige - svensk - Läkemedelsverket (Medical Products Agency)

methylphenidate generis 18 mg depottablett

generis farmacêutica, sa - metylfenidathydroklorid - depottablett - 18 mg - laktosmonohydrat hjälpämne; metylfenidathydroklorid 14,76 mg aktiv substans; metylfenidathydroklorid 3,24 mg aktiv substans

Methylphenidate Generis 54 mg Depottablett Sverige - svensk - Läkemedelsverket (Medical Products Agency)

methylphenidate generis 54 mg depottablett

generis farmacêutica, sa - metylfenidathydroklorid - depottablett - 54 mg - metylfenidathydroklorid 44,28 mg aktiv substans; metylfenidathydroklorid 9,72 mg aktiv substans; laktosmonohydrat hjälpämne